Management of viral hepatitis in patients with haematological malignancy and in patients undergoing haemopoietic stem cell transplantation: recommendations of the 5th European Conference on Infections in Leukaemia (ECIL-5)
- 1 May 2016
- journal article
- review article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 16 (5) , 606-617
Abstract
No abstract availableKeywords
This publication has 144 references indexed in Scilit:
- Pretransplantation Liver Function Impacts on the Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: A Study of 455 PatientsTransplantation and Cellular Therapy, 2011
- Hepatitis delta virusThe Lancet, 2011
- Rituximab-associated hepatitis B virus (HBV) reactivation in lymphoproliferative diseases: meta-analysis and examination of FDA safety reportsAnnals of Oncology, 2010
- Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCTBone Marrow Transplantation, 2010
- Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancerJournal of Viral Hepatitis, 2009
- Hepatitis B Virus Reactivation following Allogeneic Hematopoietic Stem Cell TransplantationTransplantation and Cellular Therapy, 2009
- Chronic hepatitis B: Update 2009 #Hepatology, 2009
- A comparison of a standard-dose prednisone regimen and mycophenolate mofetil combined with a lower prednisone dose in chinese adults with idiopathic nephrotic syndrome who were carriers of hepatitis B surface antigen: A prospective cohort studyClinical Therapeutics, 2009
- Long‐term surveillance of haematopoietic stem cell recipients with resolved hepatitis B: high risk of viral reactivation even in a recipient with a vaccinated donorJournal of Viral Hepatitis, 2006
- Guide to Development of Practice GuidelinesClinical Infectious Diseases, 2001